Control Bionics is all set to launch its NeuroNode Trilogy technology in Japan in partnership with major assistive technology distributor, Double R&D Co Ltd, under an initiative led by CBL’s Japanese executive, Erica Kitayama.
CBL has advanced the deal to provide its technology benefits to Japanese people with medical conditions such as ALS, cerebral palsy, intellectual disability, stroke and traumatic brain injuries.
Read the whole article for more on:
- Specifics of the CBL-Double R&D agreement
- A glimpse into CBL’s life-changing technology
- Exploring the realm of Double R&D